Literature DB >> 851711

Dangerous reactions to treatment of onchocerciasis with diethylcarbamazine.

A D Bryceson, D A Warrell, H M Pope.   

Abstract

Nine Nigerians with severe onchocerciasis who were treated with diethylcarbamazine developed clinical changes, ranging in severity from mild itching to distress, cough, and syncope. Physiological changes (fever, tachypnoea, tachycardia, or hypotension) were seen in eight. In five patients the systolic blood pressure fell by more than 25 mm Hg, and one patient collapsed on attempting to sit up. Circulating eosinophils decreased profoundly in all cases, reaching their lowest levels just before or during the clinical and physiological changes. A fall in serum complement (c3) accompanied the reaction but there was no fall in antibody titre. Diethylcarbamazine probably acts on the parasite's cuticle, thus exposing it to the body's defence mechansims. The reaction coincides with the death of microfilariae, and the accompanying physiological changes may be so severe, even in generally healthy patients, the treatment should perferably be started in hospital.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 851711      PMCID: PMC1605656          DOI: 10.1136/bmj.1.6063.742

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  A quantitative survey of onchocerciasis in persons under twenty years of age in an endemic area of Northern Nigeria; with a consideration of the epidemiology based on a mathematical hypothesis, by F. N. Macnamara.

Authors:  R W CROSSKEY; M E CROSSKEY
Journal:  Ann Trop Med Parasitol       Date:  1959-04

2.  'Hetrazan' eosinopenia in onchocerciasis. A preliminary communication.

Authors:  G L MONEY
Journal:  J Trop Med Hyg       Date:  1960-10

3.  Clinical and laboratory changes consequent to diethylcarbamazine in patients with onchocerciasis.

Authors:  L E Fazen; R I Anderson; L E Fazen; H F Marroquin
Journal:  Am J Trop Med Hyg       Date:  1976-03       Impact factor: 2.345

4.  A histological study of onchocerciasis treated with hetrazan.

Authors:  F HAWKING
Journal:  Br Med J       Date:  1952-05-10

5.  The mode of action of hetrazan on filarial worms.

Authors:  F HAWKING; P SEWELL; J P THURSTON
Journal:  Br J Pharmacol Chemother       Date:  1950-06

6.  Onchocercal dermatitis: ultrastructural studies of microfilariae and host tissues, before and after treatment with diethylcarbamazine (Hetrazan).

Authors:  D W Gibson; D H Connor; H L Brown; H Fuglsang; J Anderson; B O Duke; A A Buck
Journal:  Am J Trop Med Hyg       Date:  1976-01       Impact factor: 2.345

7.  Antigenic diversity among Onchocerca volvulus in Nigeria, and immunological differences between onchocerciasis in the savanna and forest of Cameroon.

Authors:  A D Bryceson; K S van Veen; A J Oduloju; B O Duke
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

8.  Onchocerciasis. Onchocercal dermatitis, lymphadenitis, and elephantiasis in the Ubangi territory.

Authors:  D H Connor; N E Morrison; F Kerdel-Vegas; H A Berkoff; F Johnson; R Tunnifliffe; F C Failing; L N Hale; K Lindquist
Journal:  Hum Pathol       Date:  1970-12       Impact factor: 3.466

9.  Letter: Collapse during treatment of onchocerciasis with diethylcarbamazine.

Authors:  H Fuglsang; J Anderson
Journal:  Trans R Soc Trop Med Hyg       Date:  1974       Impact factor: 2.184

10.  Studies of the mechanism of the Jarisch-Herxheimer reaction in louse-borne relapsing fever: evidence for the presence of circulating Borrelia endotoxin.

Authors:  A D Bryceson; K E Cooper; D A Warrell; P L Perine; E H Parry
Journal:  Clin Sci       Date:  1972-09       Impact factor: 6.124

View more
  14 in total

Review 1.  Diethylcarbamazine in the treatment of patients with onchocerciasis.

Authors:  K Awadzi; H M Gilles
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

2.  Decrease in adverse reactions after repeated ivermectin treatment in onchocerciasis.

Authors:  A Van der Lelij; A Rothova; N Klaassen-Broekema; W R Wilson; R F Barbe; J S Stilma
Journal:  Doc Ophthalmol       Date:  1990-10       Impact factor: 2.379

3.  Eye screening in 2234 Sierra Leonean school students and detection of onchocerciasis.

Authors:  J S Stilma; D M Ebley; S M Coker
Journal:  Doc Ophthalmol       Date:  1983-12-15       Impact factor: 2.379

4.  Further studies on the treatment of ocular onchocerciasis with diethylcarbamazine and suramin.

Authors:  J Anderson; H Fuglsang
Journal:  Br J Ophthalmol       Date:  1978-07       Impact factor: 4.638

5.  Eosinophil granule cationic proteins regulate the classical pathway of complement.

Authors:  J M Weiler; R E Edens; C S Bell; G J Gleich
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

6.  Aggregation of equine platelets by Onchocerca cervicalis collagen.

Authors:  L A McConnell; R W Leid
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

7.  Effects of various concentrations of diethylcarbamazine citrate applied as eye drops in ocular onchocerciasis, and the possibilities of improved therapy from continuous non-pulsed delivery.

Authors:  B R Jones; J Anderson; H Fuglsang
Journal:  Br J Ophthalmol       Date:  1978-07       Impact factor: 4.638

8.  Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.

Authors:  A C Bird; H el-Sheikh; J Anderson; H Fuglsang
Journal:  Br J Ophthalmol       Date:  1980-03       Impact factor: 4.638

9.  Ocular onchocerciasis: current management and future prospects.

Authors:  Olufemi Emmanuel Babalola
Journal:  Clin Ophthalmol       Date:  2011-10-13

10.  Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis.

Authors:  Kwablah Awadzi
Journal:  Filaria J       Date:  2003-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.